It looks like it's a replica of the COBRA protocol. Deiberately so.
I like the separation of the prostate fossa versus outside the fossa assessments: outside the fossa is where 64Cu-SAR-bisPSMA scored 9 in 9 true positive rate.
The other one that's caught my eye is the Evaluation of the "biochemical (PSA) response following salvage radiotherapy by 64Cu-SAR-bisPSMA and 68Ga PSMA-11 PET/CT imaging parameters in the presence of normal testosterone levels". I'm gonna think a bit about this one.
For now, it's today's bombshell announcements about programme changes. I need time to digest.
CU6 Price at posting:
$1.78 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)